,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Febrile neutropenia,1,16862746
1,22.1,Embolism,6,16862746
0,22.1,Ventricular hypokinesia,1,16862749
0,22.1,Marasmus,5,16862770
1,22.1,General physical health deterioration,6,16862770
2,22.1,Dysphagia,5,16862770
3,22.1,Dementia,3,16862770
4,22.1,Pneumonia aspiration,3,16862770
5,22.1,Decubitus ulcer,3,16862770
0,22.0,Cardiac failure,5,16862821
1,22.0,Hypotension,5,16862821
2,22.0,Pneumonia,5,16862821
3,22.0,Neutrophil count decreased,5,16862821
0,22.0,Gait inability,6,16862845
1,22.0,Ascites,6,16862845
2,22.0,Asthenia,6,16862845
3,22.0,Nausea,6,16862845
4,22.0,Pain,6,16862845
0,22.0,Thrombosis in device,6,16862849
1,22.0,Neoplasm progression,3,16862849
0,22.0,Injection site mass,1,16862857
1,22.0,Injection site pain,1,16862857
2,22.0,Amnesia,3,16862857
3,22.0,Product dose omission,6,16862857
0,22.0,Death,5,16862873
0,22.0,Drug resistance,6,16862886
1,22.0,Malignant neoplasm progression,6,16862886
0,22.0,Platelet count decreased,6,16862887
0,22.0,Acute kidney injury,1,16862951
1,22.0,Sudden death,5,16862951
0,22.0,Transaminases abnormal,6,16862955
1,22.0,Metastases to liver,6,16862955
2,22.0,Wrong technique in product usage process,6,16862955
3,22.0,Neurotoxicity,6,16862955
4,22.0,Metastases to lymph nodes,6,16862955
5,22.0,Malignant neoplasm progression,6,16862955
6,22.0,Metastases to lung,6,16862955
7,22.0,Anaemia,6,16862955
8,22.0,Metastases to bone,6,16862955
9,22.0,Breast cancer,6,16862955
0,22.1,Radiation pneumonitis,2,16862982
0,22.0,Small intestinal obstruction,2,16862983
0,22.0,Drug resistance,6,16863003
1,22.0,Malignant neoplasm progression,6,16863003
0,22.0,Hepatocellular injury,3,16863011
1,22.0,Cholestasis,3,16863011
0,22.1,Spinal cord infection,4,16863036
1,22.1,Hepatocellular injury,3,16863036
0,22.1,Pneumonia aspiration,3,16863077
1,22.1,Prostate cancer,5,16863077
2,22.1,Hepatic function abnormal,1,16863077
0,22.0,Myocardial infarction,5,16863082
1,22.0,Hypokalaemia,6,16863082
2,22.0,Dehydration,6,16863082
3,22.0,Small cell lung cancer,6,16863082
4,22.0,Sepsis,5,16863082
5,22.0,Lung infection,5,16863082
6,22.0,Neutrophil count decreased,6,16863082
7,22.0,Hypocalcaemia,6,16863082
8,22.0,White blood cell count decreased,6,16863082
9,22.0,Off label use,6,16863082
10,22.0,Lymphocyte count decreased,6,16863082
11,22.0,Vomiting,6,16863082
12,22.0,Diarrhoea,6,16863082
0,22.0,Therapy partial responder,6,16863097
1,22.0,Thrombocytopenia,6,16863097
2,22.0,Hepatocellular injury,6,16863097
3,22.0,Malignant neoplasm progression,6,16863097
4,22.0,Rash,6,16863097
5,22.0,Neutropenia,6,16863097
0,22.0,Cystitis,6,16863125
1,22.0,Death,5,16863125
0,22.0,Neutrophil count decreased,5,16863127
1,22.0,Hypotension,5,16863127
2,22.0,Cardiac failure,5,16863127
3,22.0,Pneumonia,5,16863127
0,22.1,Acute kidney injury,6,16863152
0,22.1,Acute kidney injury,1,16863167
1,22.1,Febrile neutropenia,1,16863167
2,22.1,Sepsis,1,16863167
3,22.1,Enterocolitis bacterial,1,16863167
4,22.1,Bone marrow failure,1,16863167
0,22.1,Hepatic failure,3,16863186
1,22.1,Proteinuria,6,16863186
2,22.1,Malignant neoplasm progression,6,16863186
0,22.1,Cardiac failure chronic,1,16863210
0,22.0,Acquired gene mutation,6,16863238
1,22.0,Malignant neoplasm progression,6,16863238
2,22.0,Drug resistance,6,16863238
0,22.1,Alopecia,2,16863245
1,22.1,Psychological trauma,6,16863245
0,22.1,Platelet count decreased,2,16863266
1,22.1,White blood cell count decreased,2,16863266
2,22.1,Bone marrow failure,6,16863266
3,22.1,Neutrophil count decreased,2,16863266
0,22.1,Productive cough,3,16863279
1,22.1,Haematemesis,1,16863279
2,22.1,Dyspnoea,2,16863279
3,22.1,Acne,1,16863279
4,22.1,Tongue exfoliation,6,16863279
5,22.1,Epistaxis,1,16863279
6,22.1,Skin exfoliation,3,16863279
7,22.1,Nasopharyngitis,2,16863279
8,22.1,Glossodynia,6,16863279
9,22.1,Pain in extremity,6,16863279
10,22.1,Muscular weakness,3,16863279
0,22.0,Cellulitis,6,16863306
1,22.0,Urinary tract disorder,6,16863306
0,22.1,Abdominal pain upper,6,16863308
1,22.1,Intestinal perforation,6,16863308
2,22.1,Dysphagia,6,16863308
3,22.1,Lethargy,6,16863308
4,22.1,Vomiting,6,16863308
5,22.1,Death,5,16863308
6,22.1,Feeding disorder,6,16863308
0,22.0,Acute myeloid leukaemia,3,16863349
1,22.0,Second primary malignancy,3,16863349
0,22.0,Fatigue,6,16863370
1,22.0,Intercepted product prescribing error,6,16863370
2,22.0,Death,5,16863370
0,22.1,Alopecia,2,16863372
1,22.1,Psychological trauma,6,16863372
0,22.1,Head and neck cancer,6,16863458
0,22.1,Bronchial fistula,1,16863462
0,22.0,Pyrexia,3,16863478
1,22.0,Bacteraemia,6,16863478
2,22.0,Depressed level of consciousness,6,16863478
3,22.0,Monoplegia,6,16863478
4,22.0,Dyspnoea,6,16863478
0,22.1,Drug resistance,3,16863512
1,22.1,Malignant neoplasm progression,3,16863512
0,22.1,Malignant neoplasm progression,6,16863513
1,22.1,Drug resistance,6,16863513
0,22.1,Drug resistance,6,16863514
1,22.1,Malignant neoplasm progression,6,16863514
2,22.1,Drug ineffective,6,16863514
0,22.1,Hot flush,3,16863528
1,22.1,Diarrhoea,1,16863528
0,22.1,Laboratory test abnormal,6,16863530
1,22.1,Haemoglobin decreased,6,16863530
0,22.1,Impaired healing,3,16863545
1,22.1,Complication associated with device,3,16863545
2,22.1,Back disorder,6,16863545
3,22.1,General physical health deterioration,6,16863545
0,22.1,Pleural effusion,6,16863592
0,22.1,Spinal compression fracture,3,16863603
1,22.1,Cancer pain,3,16863603
2,22.1,Thoracic vertebral fracture,3,16863603
3,22.1,Haemangioma of bone,3,16863603
0,22.1,Disseminated intravascular coagulation,,16863604
1,22.1,Gingival swelling,5,16863604
2,22.1,Subdural haemorrhage,5,16863604
3,22.1,Headache,5,16863604
4,22.1,Swollen tongue,5,16863604
5,22.1,Vomiting,5,16863604
0,22.1,Malignant neoplasm progression,6,16863630
1,22.1,Radiation pneumonitis,2,16863630
0,22.1,Leukopenia,1,16863651
0,22.1,Sleep disorder,6,16863664
1,22.1,Hypophagia,6,16863664
2,22.1,Feeling hot,6,16863664
3,22.1,Vomiting,6,16863664
4,22.1,Hyperhidrosis,6,16863664
5,22.1,Gastrooesophageal reflux disease,6,16863664
6,22.1,Full blood count decreased,6,16863664
7,22.1,Blood pressure increased,3,16863664
8,22.1,Hypotension,1,16863664
9,22.1,Dizziness,6,16863664
10,22.1,Nausea,6,16863664
11,22.1,Rectal haemorrhage,1,16863664
12,22.1,Flatulence,6,16863664
13,22.1,Headache,6,16863664
14,22.1,Asthenia,6,16863664
0,22.0,Malignant neoplasm progression,6,16863666
1,22.0,Pulmonary mass,1,16863666
2,22.0,Product dose omission,6,16863666
0,22.1,Bone marrow failure,1,16863668
1,22.1,Blood creatinine increased,6,16863668
2,22.1,Fatigue,3,16863668
3,22.1,Blood potassium decreased,1,16863668
4,22.1,Head discomfort,1,16863668
5,22.1,Haemoglobin decreased,1,16863668
6,22.1,Pain,1,16863668
7,22.1,Hyperhidrosis,3,16863668
8,22.1,Platelet count decreased,3,16863668
9,22.1,Feeling abnormal,1,16863668
10,22.1,Breath odour,6,16863668
11,22.1,Blood magnesium decreased,1,16863668
12,22.1,Candida infection,1,16863668
13,22.1,Dyspnoea exertional,2,16863668
14,22.1,Dermatitis contact,6,16863668
15,22.1,Underdose,6,16863668
0,22.1,Contusion,1,16863672
1,22.1,Psychomotor hyperactivity,2,16863672
2,22.1,Red blood cell count decreased,1,16863672
3,22.1,Blood bilirubin increased,6,16863672
4,22.1,Platelet count decreased,2,16863672
5,22.1,Blood calcium increased,1,16863672
6,22.1,White blood cell count decreased,1,16863672
0,22.0,Kidney infection,6,16863676
0,22.0,Asthma,6,16863705
1,22.0,Pleurisy,6,16863705
0,22.1,Renal impairment,6,16863719
1,22.1,Hepatic function abnormal,6,16863719
2,22.1,Myocarditis,1,16863719
3,22.1,Malignant neoplasm progression,6,16863719
4,22.1,Adrenal insufficiency,6,16863719
5,22.1,Pemphigoid,6,16863719
0,22.1,Off label use,6,16863720
1,22.1,Toxic epidermal necrolysis,6,16863720
2,22.1,Stevens-Johnson syndrome,2,16863720
0,22.1,Immune-mediated hepatitis,1,16863737
0,22.1,Suicidal ideation,1,16863754
0,22.0,Hyperbilirubinaemia,6,16863779
0,22.1,Renal impairment,3,16863844
0,22.1,Haematotoxicity,1,16863868
1,22.1,Neutropenia,1,16863868
0,22.0,Drug resistance,6,16863902
1,22.0,Acquired gene mutation,6,16863902
2,22.0,Malignant neoplasm progression,6,16863902
0,22.0,Drug resistance,6,16863912
1,22.0,Acquired gene mutation,6,16863912
2,22.0,Malignant neoplasm progression,6,16863912
0,22.1,Hepatic enzyme increased,3,16863924
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,16863924
2,22.1,Hepatotoxicity,,16863924
3,22.1,Liver injury,5,16863924
4,22.1,Abdominal injury,5,16863924
5,22.1,Swelling,,16863924
6,22.1,Blood bilirubin increased,5,16863924
0,22.1,Leukopenia,6,16863934
1,22.1,Hypokalaemia,6,16863934
0,22.1,Pleural effusion,6,16863971
1,22.1,Portal hypertension,6,16863971
2,22.1,Ulcer haemorrhage,6,16863971
3,22.1,Hepatic cirrhosis,6,16863971
4,22.1,Hepatic fibrosis,3,16863971
5,22.1,Upper gastrointestinal haemorrhage,3,16863971
6,22.1,Generalised oedema,3,16863971
7,22.1,Pneumonitis,6,16863971
0,22.1,Enterocolitis,1,16864054
0,22.1,Hypotension,6,16864059
1,22.1,Immune system disorder,6,16864059
2,22.1,Malignant neoplasm progression,6,16864059
3,22.1,Pulmonary haemorrhage,6,16864059
4,22.1,Pulmonary oedema,6,16864059
0,22.1,Hypersensitivity,1,16864075
0,22.1,Malignant neoplasm progression,6,16864083
1,22.1,Pneumonia,6,16864083
0,22.0,Death,5,16864085
0,22.1,Death,5,16864087
1,22.1,Spinal fracture,6,16864087
0,22.0,Rash,1,16864147
0,22.1,Dizziness,1,16864150
1,22.1,Diarrhoea,1,16864150
0,22.1,Fall,6,16864161
1,22.1,Decreased appetite,6,16864161
2,22.1,Asthenia,6,16864161
3,22.1,Nausea,6,16864161
4,22.1,Oral pain,6,16864161
5,22.1,Vomiting,6,16864161
6,22.1,Fatigue,6,16864161
7,22.1,Retching,6,16864161
8,22.1,Gait disturbance,6,16864161
9,22.1,Weight decreased,6,16864161
10,22.1,Blood glucose increased,6,16864161
11,22.1,Diarrhoea,6,16864161
0,22.0,Heart rate increased,6,16864183
1,22.0,Blood pressure systolic,6,16864183
0,22.0,Dehydration,6,16864189
1,22.0,Joint stiffness,6,16864189
2,22.0,Underdose,6,16864189
3,22.0,Intestinal obstruction,1,16864189
4,22.0,Hyponatraemia,6,16864189
5,22.0,Emotional disorder,6,16864189
6,22.0,Musculoskeletal stiffness,6,16864189
7,22.0,Emotional distress,6,16864189
8,22.0,Blood creatinine increased,6,16864189
0,22.0,Paraesthesia,6,16864205
1,22.0,Neuropathy peripheral,6,16864205
2,22.0,Muscular weakness,6,16864205
0,22.0,Diabetic ketoacidosis,1,16864214
1,22.0,Immune-mediated adverse reaction,1,16864214
0,22.1,Sudden death,5,16864247
1,22.1,Acute kidney injury,1,16864247
0,22.0,Lung disorder,6,16864293
0,22.0,Headache,6,16864334
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16864414
0,22.0,Ascites,6,16864420
0,22.1,Interstitial lung disease,5,16864425
1,22.1,Deep vein thrombosis,6,16864425
2,22.1,Haematuria,6,16864425
3,22.1,Antiphospholipid syndrome,5,16864425
4,22.1,Pulmonary alveolar haemorrhage,5,16864425
5,22.1,Acute respiratory failure,5,16864425
6,22.1,Diffuse alveolar damage,5,16864425
0,22.0,Fatigue,6,16864427
1,22.0,Thrombocytopenia,6,16864427
2,22.0,Bone marrow failure,6,16864427
3,22.0,Neutropenia,6,16864427
0,22.0,Fatigue,6,16864428
1,22.0,Diarrhoea,6,16864428
2,22.0,Pulmonary mass,6,16864428
0,22.0,Death,5,16864429
0,22.0,Hepatic failure,5,16864452
0,22.0,Urinary bladder haemorrhage,1,16864471
1,22.0,Wound infection,2,16864471
2,22.0,Skin laceration,2,16864471
3,22.0,Cellulitis,2,16864471
4,22.0,Urinary tract infection,2,16864471
0,22.0,Drug ineffective,6,16864480
1,22.0,Colorectal cancer metastatic,6,16864480
2,22.0,Adenocarcinoma,1,16864480
3,22.0,Diarrhoea,1,16864480
4,22.0,Hypertension,6,16864480
5,22.0,Fatigue,1,16864480
6,22.0,Disease progression,6,16864480
7,22.0,Thrombocytopenia,1,16864480
8,22.0,Fatigue,6,16864480
0,22.0,Fall,6,16864537
0,22.0,Drug ineffective,6,16864551
1,22.0,Allergy to chemicals,6,16864551
2,22.0,Peritoneal disorder,6,16864551
0,22.0,Vomiting,1,16864559
1,22.0,Dyspepsia,1,16864559
2,22.0,Nausea,1,16864559
3,22.0,Alopecia,1,16864559
4,22.0,Constipation,1,16864559
5,22.0,Pneumonia,6,16864559
0,22.1,White blood cell count decreased,6,16864565
1,22.1,Heart rate increased,2,16864565
2,22.1,Rhinorrhoea,6,16864565
3,22.1,Haematochezia,6,16864565
4,22.1,Productive cough,2,16864565
5,22.1,Vomiting,6,16864565
6,22.1,Asthma,6,16864565
7,22.1,Cardiac failure,6,16864565
8,22.1,Chest discomfort,2,16864565
9,22.1,Protein total decreased,6,16864565
10,22.1,Cough,2,16864565
11,22.1,Peripheral swelling,6,16864565
12,22.1,Anaemia,6,16864565
13,22.1,Dyspnoea,2,16864565
0,22.0,Neutropenic sepsis,6,16864573
1,22.0,Pancytopenia,6,16864573
0,22.1,Pneumonia,5,16864576
0,22.0,Poor peripheral circulation,5,16864578
1,22.0,Product use in unapproved indication,6,16864578
2,22.0,Stomatitis,1,16864578
3,22.0,Mouth ulceration,1,16864578
4,22.0,Hypotension,5,16864578
5,22.0,Feeding disorder,1,16864578
0,22.0,Pneumonitis,6,16864592
0,22.0,Brain oedema,6,16864623
0,22.0,Leukopenia,2,16864641
1,22.0,Weight decreased,6,16864641
2,22.0,Arthralgia,6,16864641
3,22.0,Motor dysfunction,6,16864641
0,22.1,Eye disorder,6,16864649
1,22.1,Hypoaesthesia,6,16864649
2,22.1,Muscular weakness,6,16864649
3,22.1,Heart rate abnormal,6,16864649
4,22.1,Weight decreased,6,16864649
5,22.1,Asthenia,6,16864649
6,22.1,Fatigue,6,16864649
7,22.1,Amnesia,6,16864649
8,22.1,Neuralgia,6,16864649
9,22.1,Tooth loss,6,16864649
10,22.1,Joint swelling,6,16864649
11,22.1,Stomatitis,6,16864649
12,22.1,Cough,6,16864649
13,22.1,Dry mouth,6,16864649
14,22.1,Prostate cancer,6,16864649
15,22.1,Nervous system disorder,6,16864649
16,22.1,Paraesthesia,6,16864649
17,22.1,Oesophagitis,6,16864649
18,22.1,Eating disorder,6,16864649
0,22.1,Rash,1,16864662
1,22.1,Rash,6,16864662
0,22.0,Malignant neoplasm progression,6,16864676
1,22.0,Pneumonitis,3,16864676
0,22.1,Pruritus,4,16864705
1,22.1,Oropharyngeal pain,1,16864705
2,22.1,Diarrhoea,4,16864705
3,22.1,Vomiting,1,16864705
4,22.1,Pyrexia,4,16864705
5,22.1,Nausea,1,16864705
6,22.1,Visual impairment,4,16864705
7,22.1,Rash,4,16864705
8,22.1,Headache,1,16864705
0,22.0,Product use in unapproved indication,6,16864706
1,22.0,General physical health deterioration,5,16864706
0,22.0,Metastases to liver,6,16864712
1,22.0,Breast cancer,6,16864712
2,22.0,Malignant neoplasm progression,6,16864712
3,22.0,Breast mass,6,16864712
4,22.0,Metastases to lung,6,16864712
0,22.0,Metastases to peritoneum,6,16864718
1,22.0,Intestinal congestion,6,16864718
2,22.0,Hydronephrosis,6,16864718
3,22.0,Carcinoembryonic antigen increased,6,16864718
4,22.0,Abdominal neoplasm,6,16864718
5,22.0,Gastrointestinal disorder,6,16864718
6,22.0,Metastases to lymph nodes,6,16864718
7,22.0,Metastases to liver,6,16864718
8,22.0,Urinary retention,6,16864718
9,22.0,Malignant neoplasm progression,6,16864718
10,22.0,Toxoplasmosis,6,16864718
11,22.0,Breast cancer,6,16864718
12,22.0,Intestinal stenosis,6,16864718
13,22.0,Lymphadenitis,6,16864718
14,22.0,Tumour marker increased,6,16864718
15,22.0,Metastases to bone,6,16864718
16,22.0,Malignant peritoneal neoplasm,6,16864718
17,22.0,Vomiting,6,16864718
0,22.0,Blood pressure decreased,6,16864809
1,22.0,Erythema,6,16864809
2,22.0,Vision blurred,6,16864809
3,22.0,Myalgia,2,16864809
4,22.0,Limb discomfort,6,16864809
5,22.0,Diarrhoea,3,16864809
6,22.0,Injection site discomfort,6,16864809
7,22.0,Inappropriate schedule of product administration,6,16864809
8,22.0,Rectal haemorrhage,2,16864809
9,22.0,Lymph node pain,6,16864809
10,22.0,Muscular weakness,6,16864809
11,22.0,Joint swelling,6,16864809
12,22.0,Gastrointestinal bacterial overgrowth,6,16864809
13,22.0,Bladder pain,6,16864809
14,22.0,Flushing,6,16864809
15,22.0,Orthostatic hypotension,6,16864809
16,22.0,Dysstasia,6,16864809
17,22.0,Sciatic nerve injury,6,16864809
18,22.0,Pain in extremity,6,16864809
19,22.0,Dizziness,6,16864809
20,22.0,Abdominal distension,2,16864809
21,22.0,Pain,6,16864809
22,22.0,Back pain,6,16864809
23,22.0,Dermatitis acneiform,6,16864809
24,22.0,Osteoarthritis,6,16864809
25,22.0,Upper respiratory tract infection,2,16864809
26,22.0,Flank pain,6,16864809
27,22.0,Wrong technique in product usage process,6,16864809
28,22.0,Anorectal discomfort,2,16864809
29,22.0,Dry eye,6,16864809
30,22.0,Hypoaesthesia,6,16864809
31,22.0,Frustration tolerance decreased,6,16864809
32,22.0,Crying,6,16864809
33,22.0,Pruritus,6,16864809
34,22.0,Rash,3,16864809
35,22.0,Weight decreased,6,16864809
36,22.0,Depressed mood,6,16864809
37,22.0,Acne,6,16864809
38,22.0,Arthritis,6,16864809
39,22.0,Petechiae,6,16864809
40,22.0,Paraesthesia,1,16864809
41,22.0,Sensory disturbance,6,16864809
42,22.0,Musculoskeletal discomfort,6,16864809
43,22.0,Nausea,6,16864809
44,22.0,Alopecia,6,16864809
45,22.0,Asthenia,6,16864809
46,22.0,Fatigue,6,16864809
47,22.0,Injection site mass,6,16864809
48,22.0,Needle issue,6,16864809
49,22.0,Cough,2,16864809
50,22.0,Musculoskeletal chest pain,2,16864809
51,22.0,Dysphonia,3,16864809
52,22.0,Injection site erythema,6,16864809
53,22.0,Injection site pain,6,16864809
54,22.0,Haemorrhoids,6,16864809
55,22.0,Haematoma,6,16864809
56,22.0,Nervousness,2,16864809
57,22.0,Lymphadenopathy,6,16864809
58,22.0,Urinary tract infection,3,16864809
59,22.0,Abdominal tenderness,2,16864809
60,22.0,Abdominal pain upper,6,16864809
61,22.0,Underdose,6,16864809
62,22.0,Oral discomfort,6,16864809
63,22.0,Skin discolouration,6,16864809
64,22.0,Musculoskeletal pain,2,16864809
65,22.0,Feeling abnormal,6,16864809
66,22.0,Fall,6,16864809
67,22.0,Injection site pain,1,16864809
68,22.0,Injection site mass,1,16864809
69,22.0,Headache,6,16864809
70,22.0,Product use in unapproved indication,6,16864809
0,22.1,Blood pressure increased,1,16864817
1,22.1,Nausea,1,16864817
2,22.1,Blood pressure increased,3,16864817
3,22.1,Dizziness,1,16864817
4,22.1,Anxiety,1,16864817
0,22.0,Hyperglycaemia,2,16864879
0,22.1,Neutropenic sepsis,5,16864967
0,22.1,Bone marrow failure,1,16864972
0,22.0,Neutropenia,6,16864982
0,22.0,Coronary artery bypass,6,16864990
1,22.0,Influenza,6,16864990
0,22.1,Nausea,5,16865009
1,22.1,Cell death,5,16865009
2,22.1,Hepatic function abnormal,5,16865009
3,22.1,Decreased appetite,5,16865009
4,22.1,Erythema,5,16865009
5,22.1,Abnormal clotting factor,5,16865009
6,22.1,Vomiting,5,16865009
7,22.1,Vitamin K decreased,3,16865009
8,22.1,Thrombocytopenia,5,16865009
9,22.1,Toxicity to various agents,5,16865009
10,22.1,Neutropenia,5,16865009
11,22.1,General physical condition abnormal,3,16865009
12,22.1,Sepsis,5,16865009
13,22.1,Palmar-plantar erythrodysaesthesia syndrome,5,16865009
14,22.1,Hepatocellular injury,5,16865009
15,22.1,Dermatitis exfoliative generalised,5,16865009
16,22.1,Mucosal inflammation,5,16865009
17,22.1,Renal impairment,5,16865009
0,22.0,Neutrophil count decreased,5,16865087
1,22.0,Hypotension,5,16865087
2,22.0,Cardiac failure,5,16865087
3,22.0,Pneumonia,5,16865087
0,22.0,Non-small cell lung cancer,5,16865138
0,22.0,Peripheral swelling,6,16865145
1,22.0,Gait inability,6,16865145
2,22.0,Testicular pain,6,16865145
3,22.0,Depression,6,16865145
4,22.0,Hot flush,6,16865145
5,22.0,Myocardial infarction,6,16865145
6,22.0,Hypertension,1,16865145
0,22.0,Photosensitivity reaction,1,16865158
1,22.0,Drug eruption,1,16865158
0,22.1,Dermatitis acneiform,6,16865178
1,22.1,Dermatitis acneiform,2,16865178
2,22.1,Dermatitis acneiform,6,16865178
0,22.1,Nasopharyngitis,6,16865202
1,22.1,Movement disorder,6,16865202
2,22.1,Pyrexia,6,16865202
3,22.1,Brain oedema,6,16865202
4,22.1,Influenza,6,16865202
0,22.0,Adrenal insufficiency,1,16865223
0,22.1,Renal impairment,6,16865239
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16865239
2,22.1,Neutropenia,5,16865239
3,22.1,Cell death,6,16865239
4,22.1,Vomiting,6,16865239
5,22.1,Nausea,6,16865239
6,22.1,Hepatic function abnormal,6,16865239
7,22.1,Thrombocytopenia,5,16865239
8,22.1,Coagulation factor deficiency,6,16865239
9,22.1,General physical health deterioration,6,16865239
10,22.1,Sepsis,6,16865239
11,22.1,Erythema,6,16865239
12,22.1,Decreased appetite,6,16865239
13,22.1,Dermatitis exfoliative generalised,6,16865239
14,22.1,Mucosal inflammation,6,16865239
0,22.0,Pituitary tumour benign,6,16865242
0,22.0,Dysgeusia,1,16865285
1,22.0,Neutropenia,1,16865285
2,22.0,Diarrhoea,3,16865285
3,22.0,Mucosal inflammation,1,16865285
4,22.0,Epistaxis,1,16865285
5,22.0,Febrile neutropenia,3,16865285
6,22.0,Cough,3,16865285
7,22.0,Dysuria,3,16865285
8,22.0,Vertigo,1,16865285
0,22.0,Asthenia,6,16865305
0,22.0,Paraesthesia,6,16865413
1,22.0,Polyneuropathy,6,16865413
0,22.0,Bone marrow failure,2,16865431
0,22.0,Bone marrow failure,6,16865490
0,22.1,Pulmonary granuloma,3,16865594
0,22.1,Tremor,1,16865596
1,22.1,Vomiting,1,16865596
2,22.1,Mean arterial pressure increased,1,16865596
3,22.1,Pyrexia,1,16865596
4,22.1,Tachycardia,1,16865596
0,22.0,Nausea,6,16865612
1,22.0,Fatigue,6,16865612
2,22.0,Diarrhoea,6,16865612
0,22.1,Nephritis,1,16865649
1,22.1,Glomerulonephritis chronic,1,16865649
0,22.1,Myelodysplastic syndrome,2,16865696
0,22.0,Nausea,2,16865748
1,22.0,Gastrooesophageal reflux disease,2,16865748
2,22.0,Hyperpyrexia,2,16865748
3,22.0,Vomiting,2,16865748
0,22.0,Dyspnoea,1,16865804
1,22.0,Back pain,1,16865804
2,22.0,Anaphylactoid reaction,1,16865804
0,22.1,Large intestinal haemorrhage,5,16865974
0,22.1,Venoocclusive liver disease,6,16866125
1,22.1,Liver injury,6,16866125
2,22.1,Condition aggravated,1,16866125
3,22.1,Portal hypertension,6,16866125
4,22.1,Varices oesophageal,1,16866125
0,22.0,Platelet count decreased,2,16866155
0,22.1,Anxiety,3,16866435
1,22.1,Platelet count decreased,1,16866435
2,22.1,Wound,6,16866435
3,22.1,Rhinorrhoea,6,16866435
4,22.1,Constipation,3,16866435
5,22.1,Headache,6,16866435
6,22.1,Aphasia,6,16866435
7,22.1,Insomnia,6,16866435
8,22.1,Blood calcium increased,3,16866435
9,22.1,Nausea,6,16866435
10,22.1,Oropharyngeal discomfort,6,16866435
0,22.1,Platelet count decreased,6,16866454
1,22.1,Decreased appetite,3,16866454
2,22.1,Intestinal obstruction,6,16866454
3,22.1,Nausea,3,16866454
4,22.1,Peripheral swelling,6,16866454
5,22.1,Dizziness,3,16866454
6,22.1,Stomatitis,3,16866454
7,22.1,Carbohydrate antigen 125 increased,6,16866454
8,22.1,Asthenia,6,16866454
0,22.0,Carbohydrate antigen 125 increased,2,16866458
1,22.0,Nodule,6,16866458
2,22.0,Platelet count decreased,6,16866458
3,22.0,Cough,3,16866458
4,22.0,Paranasal sinus hypersecretion,6,16866458
5,22.0,Peripheral swelling,1,16866458
6,22.0,Product dose omission,6,16866458
0,22.1,Type 2 diabetes mellitus,6,16866473
1,22.1,Blood pressure increased,2,16866473
2,22.1,Blood iron increased,2,16866473
3,22.1,Nasal congestion,6,16866473
4,22.1,Constipation,2,16866473
5,22.1,Muscular weakness,1,16866473
6,22.1,Heart rate increased,2,16866473
7,22.1,Asthenia,3,16866473
8,22.1,Eastern Cooperative Oncology Group performance status worsened,6,16866473
9,22.1,Dyspnoea exertional,1,16866473
10,22.1,Red blood cell count decreased,1,16866473
11,22.1,Ear irrigation,6,16866473
12,22.1,Fatigue,3,16866473
0,22.1,Disease progression,,16866612
0,22.0,Malignant neoplasm progression,6,16866620
0,22.0,Dyspnoea,4,16866638
1,22.0,Oxygen saturation decreased,4,16866638
0,22.0,Alopecia,6,16866641
1,22.0,Therapeutic response unexpected,3,16866641
2,22.0,Eye irritation,3,16866641
3,22.0,Pain of skin,3,16866641
4,22.0,Lung neoplasm malignant,3,16866641
5,22.0,Eye swelling,3,16866641
6,22.0,Pruritus,3,16866641
0,22.0,Vomiting,1,16866703
1,22.0,Nausea,1,16866703
0,22.1,Insomnia,3,16866730
1,22.1,Memory impairment,3,16866730
2,22.1,Diarrhoea,1,16866730
3,22.1,Dyspepsia,1,16866730
4,22.1,Constipation,2,16866730
5,22.1,Gastric disorder,1,16866730
6,22.1,Abdominal pain upper,6,16866730
7,22.1,Haemoglobin decreased,6,16866730
8,22.1,Amnesia,3,16866730
9,22.1,Hunger,1,16866730
10,22.1,Hypoaesthesia,3,16866730
11,22.1,Eosinophil count decreased,6,16866730
12,22.1,Vision blurred,6,16866730
13,22.1,Anal incontinence,6,16866730
14,22.1,Hyperhidrosis,3,16866730
15,22.1,Fall,6,16866730
16,22.1,Somnolence,6,16866730
17,22.1,Neutrophil count decreased,6,16866730
18,22.1,Snoring,1,16866730
19,22.1,Oral discomfort,1,16866730
20,22.1,Pain,1,16866730
21,22.1,White blood cell count increased,6,16866730
22,22.1,Rhinorrhoea,3,16866730
23,22.1,Dyspepsia,6,16866730
24,22.1,Increased appetite,1,16866730
25,22.1,Burn oesophageal,1,16866730
26,22.1,Dry skin,3,16866730
27,22.1,Haemorrhoids,2,16866730
28,22.1,Anal fissure,2,16866730
29,22.1,Corrosive gastritis,1,16866730
30,22.1,Haematochezia,1,16866730
31,22.1,Pain in extremity,3,16866730
32,22.1,General physical health deterioration,3,16866730
33,22.1,Anal fissure haemorrhage,2,16866730
34,22.1,Lacrimation increased,6,16866730
35,22.1,Malaise,1,16866730
36,22.1,Leukopenia,6,16866730
37,22.1,Gastrointestinal sounds abnormal,6,16866730
38,22.1,Haematocrit decreased,2,16866730
39,22.1,White blood cell count decreased,6,16866730
0,22.1,Myocardial infarction,5,16866755
1,22.1,Decreased appetite,6,16866755
0,22.1,Hypertension,1,16866779
1,22.1,Leukopenia,1,16866779
2,22.1,Vomiting,1,16866779
3,22.1,Neutropenia,1,16866779
0,22.0,Death,5,16866789
0,22.0,Bone marrow failure,1,16866794
0,22.0,Pericardial effusion,6,16866906
0,22.0,Influenza,3,16866960
1,22.0,Nausea,3,16866960
2,22.0,Back pain,3,16866960
3,22.0,Bone pain,3,16866960
4,22.0,Rash,3,16866960
5,22.0,Trichorrhexis,3,16866960
6,22.0,Somnolence,3,16866960
7,22.0,Dyspnoea,3,16866960
8,22.0,Pruritus generalised,3,16866960
9,22.0,Urinary tract inflammation,3,16866960
10,22.0,Pyrexia,3,16866960
0,22.0,Interstitial lung disease,6,16867004
1,22.0,Leukopenia,6,16867004
2,22.0,Hepatic function abnormal,6,16867004
3,22.0,Renal impairment,6,16867004
4,22.0,Pneumonia bacterial,6,16867004
5,22.0,Nausea,6,16867004
6,22.0,Neutropenia,6,16867004
0,22.1,Tumour cavitation,3,16867025
0,22.1,Circulatory collapse,6,16867127
1,22.1,Injection site warmth,6,16867127
2,22.1,Anaphylactic shock,6,16867127
3,22.1,Injection site induration,6,16867127
4,22.1,Erythema,6,16867127
5,22.1,Rib fracture,6,16867127
6,22.1,Lip swelling,6,16867127
7,22.1,Injection site erythema,6,16867127
0,22.1,Off label use,6,16867128
1,22.1,Prescribed underdose,6,16867128
2,22.1,Cardiac failure,2,16867128
0,22.0,Cardio-respiratory arrest,5,16867129
0,22.1,Pneumonia klebsiella,1,16867174
1,22.1,Oesophagitis,1,16867174
2,22.1,Asthenia,1,16867174
3,22.1,Drug interaction,6,16867174
4,22.1,Diarrhoea,1,16867174
5,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16867174
6,22.1,Pharyngeal inflammation,1,16867174
7,22.1,Pseudomonas test positive,1,16867174
8,22.1,Rash,1,16867174
9,22.1,Candida infection,1,16867174
10,22.1,Stomatitis,1,16867174
11,22.1,Pancytopenia,1,16867174
0,22.0,Blood alkaline phosphatase increased,6,16867515
1,22.0,Alanine aminotransferase increased,6,16867515
2,22.0,General physical health deterioration,6,16867515
3,22.0,Aspartate aminotransferase increased,6,16867515
4,22.0,Gamma-glutamyltransferase increased,6,16867515
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16867560
1,22.1,Renal disorder,2,16867560
0,22.1,Loss of consciousness,6,16867606
1,22.1,Death,5,16867606
0,22.1,Musculoskeletal stiffness,6,16867696
1,22.1,Constipation,6,16867696
2,22.1,Haemoptysis,6,16867696
3,22.1,Asthenia,6,16867696
4,22.1,Influenza,3,16867696
5,22.1,Decreased appetite,6,16867696
6,22.1,Nausea,6,16867696
7,22.1,Abdominal discomfort,6,16867696
0,22.0,Thrombocytopenia,2,16867721
0,22.1,Mucosal infection,1,16867787
0,22.1,Seizure,1,16867799
0,22.1,Haemophagocytic lymphohistiocytosis,1,16867830
0,22.0,Drug ineffective,6,16867845
0,22.0,Lymphadenopathy,3,16867882
0,22.0,Chronic obstructive pulmonary disease,6,16867888
1,22.0,Therapy non-responder,6,16867888
2,22.0,Asthenia,6,16867888
3,22.0,Colitis,3,16867888
0,22.1,Nausea,1,16867905
1,22.1,Headache,1,16867905
2,22.1,Thirst,1,16867905
3,22.1,Ejection fraction decreased,1,16867905
4,22.1,Vomiting,1,16867905
5,22.1,Nasopharyngitis,1,16867905
0,22.0,Metastases to central nervous system,2,16867929
0,22.0,Extra dose administered,6,16867935
1,22.0,Hip fracture,6,16867935
2,22.0,Fall,6,16867935
0,22.1,Nasal congestion,6,16867960
1,22.1,Fluid retention,6,16867960
2,22.1,Dry mouth,6,16867960
3,22.1,Ocular discomfort,6,16867960
4,22.1,Arrhythmia,6,16867960
0,22.0,Thrombocytopenia,5,16868004
0,22.0,Pyrexia,1,16868006
1,22.0,Weight increased,6,16868006
2,22.0,Chest pain,6,16868006
3,22.0,Chest discomfort,6,16868006
4,22.0,Renal cyst,6,16868006
5,22.0,Cough,2,16868006
6,22.0,Pain,1,16868006
7,22.0,Aspartate aminotransferase increased,6,16868006
8,22.0,Alanine aminotransferase increased,6,16868006
9,22.0,Pneumonia,6,16868006
10,22.0,Hepatomegaly,6,16868006
0,22.1,Intestinal perforation,5,16868047
0,22.0,Diarrhoea,6,16868048
1,22.0,Off label use,6,16868048
2,22.0,Product use in unapproved indication,6,16868048
0,22.0,Herpes zoster,2,16868051
0,22.1,Fatigue,3,16868086
1,22.1,Hypersomnia,3,16868086
2,22.1,Hepatic cancer,6,16868086
3,22.1,Wound haemorrhage,3,16868086
4,22.1,Feeling abnormal,3,16868086
5,22.1,Confusional state,1,16868086
6,22.1,Amnesia,3,16868086
7,22.1,Asthenia,3,16868086
8,22.1,Fall,6,16868086
9,22.1,"Hallucination, auditory",3,16868086
10,22.1,Impaired driving ability,6,16868086
11,22.1,Dysstasia,6,16868086
12,22.1,Dizziness,3,16868086
13,22.1,Defaecation disorder,6,16868086
14,22.1,Decubitus ulcer,3,16868086
0,22.1,Neoplasm progression,6,16868095
1,22.1,White blood cell count decreased,6,16868095
2,22.1,Cellulitis,1,16868095
0,22.1,Alopecia,3,16868102
1,22.1,Hair disorder,3,16868102
2,22.1,Madarosis,3,16868102
3,22.1,Hair texture abnormal,3,16868102
4,22.1,Hair colour changes,3,16868102
0,22.1,Hair disorder,3,16868106
1,22.1,Hair colour changes,3,16868106
2,22.1,Alopecia,3,16868106
3,22.1,Madarosis,3,16868106
4,22.1,Hair texture abnormal,3,16868106
0,22.1,Alopecia,3,16868114
1,22.1,Irritability,6,16868114
2,22.1,Weight increased,6,16868114
3,22.1,Muscle spasms,6,16868114
4,22.1,Fatigue,6,16868114
0,22.1,Hair texture abnormal,3,16868117
1,22.1,Hair disorder,3,16868117
2,22.1,Madarosis,3,16868117
3,22.1,Hair colour changes,3,16868117
4,22.1,Alopecia,3,16868117
0,22.1,Compression fracture,6,16868118
1,22.1,Neoplasm progression,3,16868118
0,22.0,Alopecia,6,16868124
0,22.1,Hair colour changes,3,16868130
1,22.1,Madarosis,3,16868130
2,22.1,Alopecia,3,16868130
3,22.1,Hair disorder,3,16868130
4,22.1,Hair texture abnormal,3,16868130
0,22.0,Alopecia,1,16868132
0,22.1,Hair colour changes,6,16868134
1,22.1,Hair disorder,6,16868134
2,22.1,Alopecia,3,16868134
3,22.1,Hair texture abnormal,6,16868134
4,22.1,Madarosis,3,16868134
0,22.1,Alopecia,3,16868136
1,22.1,Hair texture abnormal,3,16868136
2,22.1,Hair colour changes,3,16868136
3,22.1,Madarosis,3,16868136
4,22.1,Hair disorder,3,16868136
0,22.1,Hair disorder,3,16868139
1,22.1,Madarosis,3,16868139
2,22.1,Alopecia,3,16868139
3,22.1,Hair texture abnormal,3,16868139
4,22.1,Hair colour changes,3,16868139
0,22.0,Arrhythmia,6,16868158
1,22.0,Vertigo,6,16868158
0,22.1,Death,,16868170
0,22.1,Hospice care,,16868183
0,22.0,Thyroid cancer,,16868185
1,22.0,Protein urine present,,16868185
2,22.0,Off label use,,16868185
0,22.0,Infection,1,16868200
1,22.0,Pancytopenia,1,16868200
0,22.1,Cerebrovascular accident,5,16868209
0,22.0,Dizziness,6,16868246
0,22.1,Pleural effusion,,16868288
1,22.1,Disease progression,,16868288
0,22.0,Paraesthesia,3,16868312
1,22.0,Neuropathy peripheral,3,16868312
0,22.1,Cerebrovascular accident,,16868333
0,22.1,Disease progression,,16868337
0,22.1,Pneumonia,1,16868355
1,22.1,Dyspnoea,1,16868355
2,22.1,Neoplasm progression,3,16868355
3,22.1,Lung infiltration,1,16868355
4,22.1,Headache,1,16868355
0,22.1,Somnolence,3,16868375
0,22.1,Fatigue,6,16868384
1,22.1,Pruritus,6,16868384
2,22.1,Alopecia,6,16868384
3,22.1,Stomatitis,6,16868384
4,22.1,Dizziness,6,16868384
5,22.1,Diarrhoea,2,16868384
6,22.1,Blood glucose decreased,6,16868384
7,22.1,Wrong product administered,6,16868384
8,22.1,Constipation,6,16868384
9,22.1,Paraesthesia,6,16868384
0,22.1,Intestinal obstruction,6,16868411
0,22.1,Syncope,1,16868425
1,22.1,Epistaxis,1,16868425
2,22.1,Anaemia,1,16868425
0,22.0,Fall,6,16868427
0,22.1,Dysarthria,3,16868433
1,22.1,Hypoaesthesia oral,3,16868433
2,22.1,Brain neoplasm,3,16868433
3,22.1,Death,5,16868433
0,22.1,Asthenia,,16868436
1,22.1,Dry skin,,16868436
2,22.1,Pruritus,,16868436
0,22.0,Death,5,16868438
0,22.1,Intentional product misuse,6,16868442
1,22.1,Red blood cell count decreased,1,16868442
2,22.1,Lacrimation increased,1,16868442
3,22.1,Photophobia,1,16868442
0,22.1,Diarrhoea,2,16868445
1,22.1,Stomatitis,6,16868445
2,22.1,Alopecia,6,16868445
3,22.1,Constipation,6,16868445
0,22.0,Retinal oedema,6,16868446
1,22.0,Macular fibrosis,6,16868446
2,22.0,Vitreous adhesions,6,16868446
0,22.0,White blood cell count decreased,6,16868450
0,22.0,Product prescribing error,6,16868451
1,22.0,Loss of personal independence in daily activities,2,16868451
0,22.1,Gait inability,1,16868458
1,22.1,Off label use,6,16868458
2,22.1,Pain in extremity,1,16868458
3,22.1,Product use issue,6,16868458
4,22.1,Neoplasm progression,1,16868458
5,22.1,Lip blister,1,16868458
0,22.1,Blood count abnormal,2,16868463
1,22.1,Nasopharyngitis,6,16868463
2,22.1,Diarrhoea,6,16868463
3,22.1,White blood cell count decreased,6,16868463
0,22.0,Fatigue,6,16868471
0,22.1,Blood count abnormal,6,16868479
0,22.1,Gastric disorder,6,16868483
1,22.1,Feeling abnormal,6,16868483
0,22.0,Neoplasm,6,16868484
1,22.0,Death,5,16868484
2,22.0,Bladder disorder,6,16868484
0,22.1,Mastitis,1,16868514
1,22.1,Erysipelas,1,16868514
0,22.1,Hypertonic bladder,3,16868530
1,22.1,Weight decreased,3,16868530
0,22.1,Disease progression,,16868539
0,22.1,Death,,16868542
0,22.1,Lipase increased,3,16868559
0,22.1,Cerebral disorder,,16868561
0,22.0,Blood count abnormal,6,16868587
1,22.0,Fatigue,6,16868587
0,22.1,Asthenia,6,16868592
1,22.1,Dysphagia,6,16868592
2,22.1,Fatigue,6,16868592
3,22.1,Death,5,16868592
4,22.1,Musculoskeletal pain,6,16868592
5,22.1,Pneumonia,6,16868592
0,22.1,Death,,16868600
0,22.0,Somnolence,6,16868602
0,22.0,Haemoglobin decreased,1,16868604
1,22.0,Platelet count decreased,1,16868604
0,22.1,Arthropod bite,6,16868615
1,22.1,Product dose omission,6,16868615
2,22.1,Alopecia,6,16868615
3,22.1,Pyrexia,1,16868615
4,22.1,White blood cell count abnormal,6,16868615
5,22.1,Gastric disorder,2,16868615
6,22.1,Malaise,6,16868615
7,22.1,Madarosis,6,16868615
8,22.1,Off label use,6,16868615
9,22.1,Product use in unapproved indication,6,16868615
10,22.1,Cognitive disorder,6,16868615
11,22.1,Stress,6,16868615
12,22.1,Influenza,2,16868615
0,22.1,Lip swelling,6,16868617
1,22.1,Fatigue,6,16868617
2,22.1,Headache,6,16868617
3,22.1,Paraesthesia oral,3,16868617
0,22.0,Arteriospasm coronary,6,16868649
1,22.0,Acute myocardial infarction,6,16868649
0,22.1,Fatigue,6,16868668
1,22.1,Night sweats,6,16868668
2,22.1,Hot flush,6,16868668
0,22.0,Neoplasm progression,6,16868671
0,22.1,Hospice care,,16868677
0,22.0,Death,5,16868681
0,22.1,Blood count abnormal,,16868687
1,22.1,Sinusitis,,16868687
0,22.1,Headache,6,16868737
1,22.1,Fatigue,6,16868737
2,22.1,Constipation,6,16868737
3,22.1,White blood cell count decreased,6,16868737
4,22.1,Decreased appetite,6,16868737
5,22.1,Hepatic enzyme increased,6,16868737
0,22.0,Hypokalaemia,6,16868742
1,22.0,Hypocalcaemia,6,16868742
0,22.1,No adverse event,6,16868758
0,22.1,Pain in jaw,6,16868765
1,22.1,Fatigue,6,16868765
2,22.1,Tooth disorder,6,16868765
3,22.1,Blood count abnormal,6,16868765
4,22.1,Nausea,6,16868765
5,22.1,White blood cell count decreased,6,16868765
6,22.1,Abdominal discomfort,6,16868765
0,22.0,Death,5,16868781
0,22.0,Coma,6,16868800
0,22.0,Second primary malignancy,3,16868816
1,22.0,Transitional cell carcinoma,3,16868816
0,22.1,Condition aggravated,1,16868817
1,22.1,Cholecystitis,1,16868817
0,22.0,Neoplasm progression,6,16868821
1,22.0,Leukopenia,6,16868821
2,22.0,Alopecia,6,16868821
3,22.0,Fatigue,6,16868821
4,22.0,Granulocytopenia,6,16868821
5,22.0,Hot flush,6,16868821
6,22.0,Anaemia,6,16868821
7,22.0,Dry skin,6,16868821
0,22.1,Tumour pain,3,16868830
0,22.0,Death,5,16868839
0,22.0,Infection,1,16868883
1,22.0,Fluid retention,6,16868883
0,22.0,Colorectal cancer metastatic,6,16868911
1,22.0,Death,5,16868911
0,22.1,Urinary tract infection,1,16868933
0,22.1,Arthralgia,6,16868953
1,22.1,Constipation,6,16868953
2,22.1,Vitamin B12 decreased,6,16868953
3,22.1,Gingival bleeding,6,16868953
4,22.1,Bone marrow failure,6,16868953
5,22.1,Hypoglycaemia,6,16868953
6,22.1,Diarrhoea,3,16868953
7,22.1,Hypertension,6,16868953
8,22.1,Sleep apnoea syndrome,6,16868953
9,22.1,Nightmare,6,16868953
10,22.1,Fatigue,6,16868953
11,22.1,Loose tooth,6,16868953
12,22.1,Blood glucose increased,6,16868953
0,22.1,Neoplasm progression,6,16868961
1,22.1,Pneumonia,6,16868961
2,22.1,Hepatic enzyme increased,6,16868961
0,22.0,Death,5,16868962
0,22.0,Vomiting,2,16868984
1,22.0,Eructation,2,16868984
2,22.0,Dyspepsia,2,16868984
3,22.0,Nausea,2,16868984
4,22.0,Abdominal distension,2,16868984
0,22.0,Death,5,16868992
0,22.0,Death,5,16868993
0,22.0,Fatigue,6,16869010
1,22.0,Nausea,6,16869010
0,22.1,Death,5,16869011
0,22.0,Nausea,1,16869017
1,22.0,Fatigue,6,16869017
2,22.0,Red blood cell count decreased,6,16869017
0,22.1,Madarosis,3,16869019
1,22.1,Hair disorder,3,16869019
2,22.1,Hair texture abnormal,3,16869019
3,22.1,Alopecia,3,16869019
4,22.1,Hair colour changes,3,16869019
0,22.1,Alopecia,3,16869020
1,22.1,Hair disorder,3,16869020
2,22.1,Hair colour changes,3,16869020
3,22.1,Madarosis,3,16869020
4,22.1,Hair texture abnormal,3,16869020
0,22.0,Intentional product use issue,6,16869035
1,22.0,Upper limb fracture,6,16869035
2,22.0,Fall,6,16869035
0,22.0,Hip fracture,6,16869043
0,22.0,Rash,6,16869059
1,22.0,Abdominal pain,6,16869059
2,22.0,Multiple organ dysfunction syndrome,6,16869059
3,22.0,Pneumonia,2,16869059
4,22.0,Septic shock,6,16869059
5,22.0,Diabetic ketoacidosis,2,16869059
6,22.0,Prescribed underdose,6,16869059
0,22.0,Metastases to bone,6,16869075
1,22.0,Intestinal metastasis,6,16869075
2,22.0,Breast cancer metastatic,6,16869075
3,22.0,Hydronephrosis,6,16869075
4,22.0,Duodenal stenosis,6,16869075
5,22.0,Vomiting,6,16869075
6,22.0,PIK3CA-activated mutation,6,16869075
7,22.0,Metastases to peritoneum,6,16869075
8,22.0,Metastases to liver,6,16869075
9,22.0,Malignant neoplasm progression,6,16869075
10,22.0,Intestinal congestion,6,16869075
11,22.0,Toxoplasmosis,6,16869075
12,22.0,Urinary retention,6,16869075
13,22.0,Metastases to lymph nodes,6,16869075
14,22.0,Metastases to bladder,6,16869075
15,22.0,Carcinoembryonic antigen increased,6,16869075
0,22.0,Febrile neutropenia,5,16869181
0,22.0,Acute pulmonary oedema,1,16869182
1,22.0,Hepatitis acute,1,16869182
0,22.0,Gastrointestinal disorder,5,16869199
0,22.1,Malignant neoplasm progression,6,16869234
1,22.1,Skin toxicity,1,16869234
2,22.1,Hypothyroidism,3,16869234
3,22.1,Adverse event,6,16869234
4,22.1,Rash pruritic,1,16869234
5,22.1,Blood thyroid stimulating hormone increased,1,16869234
0,22.0,Blood test abnormal,,16869338
1,22.0,Unevaluable event,3,16869338
0,22.0,Metastases to peritoneum,6,16869358
1,22.0,Oncologic complication,6,16869358
2,22.0,Ascites,6,16869358
3,22.0,Haematotoxicity,6,16869358
0,22.1,Product use in unapproved indication,6,16869384
1,22.1,Application site erythema,1,16869384
2,22.1,Application site pain,1,16869384
0,22.0,Seizure,6,16869390
1,22.0,Hemiparesis,5,16869390
2,22.0,Meningoencephalitis herpetic,5,16869390
3,22.0,Cerebrovascular accident,5,16869390
0,22.0,Headache,2,16869391
1,22.0,Hypoacusis,2,16869391
2,22.0,Fungal infection,3,16869391
3,22.0,Abdominal discomfort,1,16869391
4,22.0,Alopecia,1,16869391
5,22.0,Macular degeneration,3,16869391
6,22.0,Pruritus,3,16869391
7,22.0,Impaired quality of life,3,16869391
8,22.0,Blood pressure increased,2,16869391
9,22.0,Cough,3,16869391
10,22.0,Blood sodium decreased,3,16869391
11,22.0,Arthropod sting,1,16869391
12,22.0,Chest pain,3,16869391
13,22.0,Malignant neoplasm progression,3,16869391
14,22.0,Diarrhoea,3,16869391
15,22.0,Vomiting,3,16869391
16,22.0,Weight decreased,2,16869391
17,22.0,Visual impairment,3,16869391
18,22.0,Kidney infection,3,16869391
19,22.0,Stomatitis,1,16869391
20,22.0,Candida infection,1,16869391
21,22.0,Pneumonia,1,16869391
22,22.0,Dysgeusia,3,16869391
23,22.0,Gingival pain,1,16869391
24,22.0,Gingival disorder,1,16869391
25,22.0,Gait disturbance,3,16869391
26,22.0,Cyst,3,16869391
27,22.0,Nausea,3,16869391
28,22.0,Fatigue,1,16869391
29,22.0,Ageusia,1,16869391
30,22.0,Skin cancer,3,16869391
31,22.0,Decreased appetite,2,16869391
0,22.1,Subcutaneous haematoma,,16869460
1,22.1,Mouth haemorrhage,,16869460
2,22.1,Drug ineffective,,16869460
3,22.1,Anti factor VIII antibody positive,,16869460
4,22.1,Dental operation,,16869460
0,22.1,Fatigue,6,16869495
1,22.1,Nausea,1,16869495
2,22.1,Product colour issue,6,16869495
3,22.1,Carbohydrate antigen 125 increased,6,16869495
4,22.1,Vomiting,6,16869495
5,22.1,Blood magnesium decreased,6,16869495
6,22.1,Lung disorder,6,16869495
0,22.0,Drug ineffective,6,16869513
1,22.0,Death,5,16869513
0,22.0,Death,5,16869517
0,22.1,Febrile neutropenia,3,16869523
1,22.1,Anaemia,3,16869523
0,22.0,Renal impairment,6,16869539
1,22.0,Blood creatinine increased,6,16869539
0,22.1,Hair texture abnormal,3,16869576
1,22.1,Madarosis,3,16869576
2,22.1,Alopecia,3,16869576
3,22.1,Depression,6,16869576
4,22.1,Hair disorder,3,16869576
5,22.1,Hair colour changes,3,16869576
6,22.1,Anxiety,6,16869576
0,22.1,Alopecia,3,16869577
1,22.1,Hair colour changes,3,16869577
2,22.1,Hair disorder,3,16869577
3,22.1,Hair texture abnormal,3,16869577
0,22.1,Renal mass,1,16869613
1,22.1,Intentional product use issue,6,16869613
0,22.1,Alopecia,2,16869652
0,22.1,Alopecia,2,16869657
0,22.1,Alopecia,2,16869666
0,22.1,Anxiety,6,16869667
1,22.1,Impaired quality of life,6,16869667
2,22.1,Pain,6,16869667
3,22.1,Emotional distress,6,16869667
4,22.1,Alopecia,2,16869667
0,22.0,Pain,6,16869680
1,22.0,Alopecia,2,16869680
2,22.0,Anxiety,6,16869680
3,22.0,Emotional distress,6,16869680
4,22.0,Impaired quality of life,6,16869680
5,22.0,Psychological trauma,6,16869680
0,22.1,Alopecia,2,16869685
1,22.1,Psychological trauma,6,16869685
0,22.1,Anxiety,6,16869703
1,22.1,Emotional distress,6,16869703
2,22.1,Pain,6,16869703
3,22.1,Impaired quality of life,6,16869703
4,22.1,Alopecia,2,16869703
5,22.1,Psychological trauma,6,16869703
0,22.1,Emotional distress,6,16869705
1,22.1,Psychological trauma,6,16869705
2,22.1,Impaired quality of life,6,16869705
3,22.1,Pain,6,16869705
4,22.1,Alopecia,2,16869705
5,22.1,Anxiety,6,16869705
0,22.1,Anxiety,6,16869707
1,22.1,Emotional distress,6,16869707
2,22.1,Pain,6,16869707
3,22.1,Impaired quality of life,6,16869707
4,22.1,Alopecia,3,16869707
5,22.1,Psychological trauma,6,16869707
0,22.1,Alopecia,2,16869713
0,22.1,Alopecia,3,16869718
1,22.1,Impaired quality of life,6,16869718
2,22.1,Emotional distress,6,16869718
3,22.1,Pain,6,16869718
4,22.1,Anxiety,6,16869718
0,22.1,Psychological trauma,6,16869725
1,22.1,Alopecia,2,16869725
0,22.1,Psychological trauma,6,16869741
1,22.1,Alopecia,2,16869741
0,22.1,Pain,6,16869742
1,22.1,Psychological trauma,6,16869742
2,22.1,Alopecia,2,16869742
3,22.1,Emotional distress,6,16869742
4,22.1,Impaired quality of life,6,16869742
5,22.1,Anxiety,6,16869742
0,22.1,Psychological trauma,6,16869743
1,22.1,Alopecia,2,16869743
0,22.1,Alopecia,2,16869745
1,22.1,Psychological trauma,6,16869745
2,22.1,Anxiety,3,16869745
0,22.1,Pain,6,16869749
1,22.1,Impaired quality of life,6,16869749
2,22.1,Anxiety,6,16869749
3,22.1,Alopecia,2,16869749
4,22.1,Emotional distress,6,16869749
5,22.1,Psychological trauma,6,16869749
0,22.1,Anxiety,3,16869752
1,22.1,Alopecia,2,16869752
2,22.1,Psychological trauma,6,16869752
0,22.1,Alopecia,2,16869756
0,22.0,Alopecia,2,16869757
1,22.0,Psychological trauma,6,16869757
0,22.1,Alopecia,2,16869758
1,22.1,Psychological trauma,6,16869758
0,22.1,Alopecia,2,16869760
1,22.1,Psychological trauma,6,16869760
0,22.0,Off label use,6,16869765
1,22.0,Venous thrombosis limb,6,16869765
0,22.0,Neoplasm progression,5,16869774
0,22.1,Confusional state,6,16869775
1,22.1,Sitting disability,3,16869775
2,22.1,Paralysis,3,16869775
3,22.1,Dysstasia,3,16869775
4,22.1,Pyrexia,1,16869775
5,22.1,Dyspnoea,6,16869775
6,22.1,Decreased immune responsiveness,6,16869775
7,22.1,Dehydration,6,16869775
8,22.1,Gait disturbance,6,16869775
9,22.1,Diarrhoea,2,16869775
10,22.1,Asthma,6,16869775
11,22.1,Muscular weakness,6,16869775
12,22.1,Delirium,3,16869775
13,22.1,Cerebral disorder,3,16869775
14,22.1,Cough,6,16869775
0,22.0,Dyspnoea,3,16869848
1,22.0,Adverse event,3,16869848
2,22.0,Anxiety,3,16869848
3,22.0,Back pain,3,16869848
4,22.0,Bone pain,3,16869848
5,22.0,Depressed mood,3,16869848
6,22.0,Blood pressure abnormal,3,16869848
7,22.0,Constipation,3,16869848
8,22.0,Cough,3,16869848
9,22.0,Depression,3,16869848
10,22.0,Fatigue,3,16869848
11,22.0,Joint swelling,3,16869848
12,22.0,Oropharyngeal discomfort,3,16869848
13,22.0,Peripheral swelling,3,16869848
14,22.0,Vital functions abnormal,3,16869848
15,22.0,Fear,3,16869848
16,22.0,Pain in extremity,3,16869848
17,22.0,Weight decreased,3,16869848
18,22.0,Feeling abnormal,3,16869848
19,22.0,Pain,3,16869848
20,22.0,Weight fluctuation,3,16869848
21,22.0,Arthralgia,3,16869848
22,22.0,General physical condition abnormal,3,16869848
23,22.0,Musculoskeletal stiffness,3,16869848
24,22.0,Nausea,3,16869848
25,22.0,Blood pressure fluctuation,3,16869848
26,22.0,Decreased appetite,3,16869848
27,22.0,Somnolence,3,16869848
28,22.0,Urticaria,3,16869848
0,22.1,Pneumonia aspiration,5,16869854
1,22.1,Febrile neutropenia,2,16869854
0,22.0,Cardiac failure congestive,6,16869877
1,22.0,Skin ulcer,6,16869877
2,22.0,Cardiac disorder,6,16869877
3,22.0,Dyspnoea,6,16869877
0,22.0,Myelodysplastic syndrome,3,16869882
1,22.0,Neutrophil count decreased,3,16869882
0,22.0,Gastrointestinal disorder,6,16869885
0,22.1,Blood potassium decreased,1,16869886
1,22.1,Muscular weakness,1,16869886
0,22.0,Disorganised speech,1,16869929
1,22.0,Abnormal behaviour,1,16869929
2,22.0,Thinking abnormal,1,16869929
3,22.0,Psychomotor hyperactivity,6,16869929
4,22.0,Indifference,2,16869929
5,22.0,Pupils unequal,6,16869929
6,22.0,Hallucination,1,16869929
0,22.0,Osteonecrosis of jaw,5,16869941
1,22.0,Product use in unapproved indication,6,16869941
0,22.0,Osteonecrosis of jaw,5,16869943
1,22.0,Product use in unapproved indication,6,16869943
0,22.1,Performance status decreased,,16869992
1,22.1,Fatigue,,16869992
2,22.1,Weight decreased,,16869992
3,22.1,Adverse drug reaction,,16869992
4,22.1,Colon cancer recurrent,,16869992
5,22.1,Depression,,16869992
6,22.1,Death,5,16869992
0,22.0,Loss of consciousness,2,16869999
0,22.0,Thrombophlebitis,2,16870000
0,22.0,Colon cancer metastatic,,16870020
0,22.1,Dysphagia,6,16870041
1,22.1,Decreased appetite,6,16870041
2,22.1,Condition aggravated,6,16870041
3,22.1,Neoplasm progression,5,16870041
0,22.1,Capillary leak syndrome,2,16870054
0,22.0,Vascular pseudoaneurysm,1,16870064
0,22.0,Diarrhoea,1,16870088
1,22.0,Hypokalaemia,1,16870088
2,22.0,Dehydration,1,16870088
0,22.1,Cerebrovascular accident,3,16870094
0,22.0,Acute pulmonary oedema,1,16870157
0,22.0,Osteonecrosis of jaw,5,16870170
0,22.1,Haematochezia,6,16870214
1,22.1,Constipation,6,16870214
2,22.1,Drug ineffective,6,16870214
3,22.1,Abdominal pain,6,16870214
4,22.1,Disease progression,6,16870214
0,22.1,Malignant ascites,6,16870215
1,22.1,Dyspnoea,6,16870215
2,22.1,Underdose,6,16870215
3,22.1,Metastatic neoplasm,6,16870215
4,22.1,Recurrent cancer,3,16870215
5,22.1,Nausea,3,16870215
6,22.1,Neutrophil count decreased,3,16870215
7,22.1,White blood cell count decreased,6,16870215
8,22.1,Fatigue,3,16870215
9,22.1,Haemoglobin decreased,6,16870215
10,22.1,Carbohydrate antigen 125 increased,3,16870215
0,22.0,Pneumonitis,6,16870218
1,22.0,Death,5,16870218
2,22.0,Skin reaction,6,16870218
0,22.0,Osteonecrosis of jaw,2,16870221
0,22.0,Death,5,16870249
0,22.0,Back pain,6,16870250
1,22.0,Death,5,16870250
0,22.0,Incoherent,6,16870251
0,22.1,Dyspnoea paroxysmal nocturnal,1,16870297
1,22.1,Cardiac failure,1,16870297
0,22.0,Disease progression,6,16870299
1,22.0,Neurotoxicity,6,16870299
2,22.0,Paraesthesia,2,16870299
0,22.0,Osteonecrosis of jaw,2,16870347
0,22.0,Blood count abnormal,5,16870348
1,22.0,Insomnia,5,16870348
2,22.0,Kidney infection,5,16870348
3,22.0,Nausea,5,16870348
4,22.0,Vomiting,5,16870348
5,22.0,Intestinal obstruction,5,16870348
6,22.0,Renal atrophy,5,16870348
7,22.0,Single functional kidney,5,16870348
8,22.0,Abdominal discomfort,5,16870348
9,22.0,Hypoalbuminaemia,5,16870348
10,22.0,Urinary tract infection,5,16870348
11,22.0,Abdominal pain upper,5,16870348
12,22.0,Dysuria,5,16870348
13,22.0,Neuropathy peripheral,5,16870348
14,22.0,Drug hypersensitivity,5,16870348
15,22.0,Oedema peripheral,5,16870348
16,22.0,Off label use,5,16870348
17,22.0,Blood creatinine increased,5,16870348
18,22.0,Central obesity,5,16870348
19,22.0,Proteinuria,5,16870348
20,22.0,Renal failure,5,16870348
21,22.0,Stress,5,16870348
22,22.0,Blood creatine increased,5,16870348
23,22.0,Blood potassium decreased,5,16870348
24,22.0,Ill-defined disorder,5,16870348
25,22.0,Sepsis,5,16870348
0,22.0,Product use in unapproved indication,6,16870355
1,22.0,Incoherent,6,16870355
2,22.0,Vomiting,6,16870355
3,22.0,Asthenia,6,16870355
4,22.0,Pyrexia,6,16870355
0,22.1,Hypoaesthesia,3,16870397
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,16870397
0,22.0,Decreased appetite,3,16870399
1,22.0,Fatigue,6,16870399
2,22.0,Insomnia,3,16870399
3,22.0,Gait disturbance,6,16870399
4,22.0,Asthenia,3,16870399
5,22.0,Product dose omission,6,16870399
6,22.0,Contusion,6,16870399
0,22.1,Weight decreased,6,16870400
1,22.1,Liver function test increased,2,16870400
2,22.1,Sinus congestion,6,16870400
3,22.1,Fatigue,3,16870400
4,22.1,Vomiting,3,16870400
5,22.1,Vomiting,1,16870400
6,22.1,Asthenia,3,16870400
7,22.1,Urinary tract infection,6,16870400
8,22.1,Blood magnesium decreased,3,16870400
9,22.1,Nasopharyngitis,6,16870400
10,22.1,Nausea,1,16870400
11,22.1,Nausea,2,16870400
12,22.1,Diarrhoea,1,16870400
13,22.1,Gastric disorder,6,16870400
14,22.1,Diarrhoea,3,16870400
15,22.1,Blood potassium decreased,1,16870400
16,22.1,Tumour marker increased,6,16870400
17,22.1,Asthenia,1,16870400
0,22.0,Malignant neoplasm progression,3,16870401
0,22.1,Rhinorrhoea,3,16870402
1,22.1,Sneezing,3,16870402
2,22.1,Gastrooesophageal reflux disease,6,16870402
0,22.0,Diarrhoea,6,16870403
1,22.0,Febrile neutropenia,6,16870403
2,22.0,Headache,6,16870403
3,22.0,Infection,6,16870403
0,22.1,Skin disorder,3,16870405
1,22.1,Somnolence,3,16870405
2,22.1,Fatigue,3,16870405
3,22.1,Therapy partial responder,6,16870405
4,22.1,Laboratory test abnormal,3,16870405
5,22.1,Malignant neoplasm progression,6,16870405
6,22.1,Liver injury,6,16870405
0,22.0,Fatigue,3,16870406
0,22.0,Nausea,2,16870407
1,22.0,Fatigue,2,16870407
2,22.0,Diarrhoea,1,16870407
3,22.0,Dizziness,2,16870407
4,22.0,Accidental underdose,6,16870407
0,22.0,Drug intolerance,6,16870408
1,22.0,Toxicity to various agents,6,16870408
0,22.0,Fatigue,1,16870411
1,22.0,Anaemia,1,16870411
2,22.0,Arthralgia,1,16870411
0,22.0,Malignant neoplasm progression,6,16870412
0,22.0,Pain in extremity,3,16870413
1,22.0,Oral pain,3,16870413
2,22.0,Unevaluable event,3,16870413
0,22.0,Haemoglobin decreased,3,16870414
1,22.0,Abdominal tenderness,3,16870414
2,22.0,Red blood cell count decreased,3,16870414
0,22.0,Blood count abnormal,6,16870416
0,22.0,Nausea,6,16870417
1,22.0,Photosensitivity reaction,6,16870417
2,22.0,Abdominal pain,6,16870417
0,22.0,Drug intolerance,6,16870418
1,22.0,Toxicity to various agents,6,16870418
0,22.0,Drug intolerance,6,16870419
1,22.0,Toxicity to various agents,6,16870419
0,22.0,Toxicity to various agents,6,16870420
1,22.0,Drug intolerance,6,16870420
0,22.0,Malignant neoplasm progression,6,16870421
0,22.0,Malignant neoplasm progression,6,16870423
0,22.0,Drug intolerance,6,16870424
1,22.0,Toxicity to various agents,6,16870424
0,22.0,Increased appetite,6,16870425
1,22.0,Abdominal distension,6,16870425
2,22.0,Cushingoid,6,16870425
3,22.0,Peripheral swelling,6,16870425
0,22.0,Malignant neoplasm progression,6,16870426
0,22.0,Fatigue,6,16870427
0,22.0,Fatigue,3,16870428
1,22.0,Cough,3,16870428
2,22.0,Bronchitis,3,16870428
3,22.0,Pyrexia,3,16870428
4,22.0,Nausea,3,16870428
0,22.0,Cough,3,16870429
0,22.0,Malignant neoplasm progression,6,16870430
0,22.1,Fatigue,3,16870431
1,22.1,Nausea,3,16870431
0,22.0,Diarrhoea,6,16870432
1,22.0,Fatigue,6,16870432
0,22.0,Drug intolerance,6,16870434
1,22.0,Toxicity to various agents,6,16870434
0,22.0,Malignant neoplasm progression,3,16870435
0,22.0,Dry throat,3,16870437
0,22.0,Anaemia,6,16870438
1,22.0,Neutropenia,6,16870438
2,22.0,Fatigue,6,16870438
3,22.0,Diarrhoea,6,16870438
0,22.0,Thrombocytopenia,2,16870439
1,22.0,Tumour marker increased,6,16870439
2,22.0,Anaemia,2,16870439
0,22.0,Toxicity to various agents,6,16870440
1,22.0,Drug intolerance,6,16870440
0,22.1,Bronchitis,6,16870441
1,22.1,Fatigue,3,16870441
2,22.1,Dehydration,6,16870441
3,22.1,Pneumonia,6,16870441
4,22.1,Accidental underdose,6,16870441
0,22.0,Malignant neoplasm progression,3,16870443
0,22.0,Malignant neoplasm progression,6,16870444
0,22.0,Drug intolerance,6,16870445
1,22.0,Toxicity to various agents,6,16870445
0,22.0,Abdominal pain upper,6,16870446
1,22.0,Product use in unapproved indication,6,16870446
0,22.0,Myalgia,6,16870447
1,22.0,Weight decreased,6,16870447
0,22.0,White blood cell count abnormal,6,16870683
1,22.0,Red blood cell count abnormal,6,16870683
2,22.0,Malignant neoplasm progression,6,16870683
0,22.0,Malaise,6,16870685
1,22.0,Adverse event,6,16870685
0,22.0,Rash,1,16870686
1,22.0,Adverse event,6,16870686
0,22.0,Taste disorder,1,16870687
0,22.0,Malignant neoplasm progression,6,16870688
1,22.0,Fatigue,1,16870688
2,22.0,Malaise,6,16870688
3,22.0,Nausea,1,16870688
0,22.0,Malignant neoplasm progression,6,16870689
0,22.0,Sunburn,6,16870690
0,22.0,Drug ineffective,6,16870691
0,22.0,Stress,3,16870692
0,22.0,Erythema,6,16870693
1,22.0,Fatigue,6,16870693
0,22.0,Flatulence,6,16870694
1,22.0,Peripheral venous disease,1,16870694
2,22.0,Peripheral swelling,1,16870694
0,22.0,Pain in extremity,6,16870695
1,22.0,Musculoskeletal pain,6,16870695
0,22.0,Blister,6,16870697
1,22.0,Photosensitivity reaction,6,16870697
0,22.0,Drug intolerance,6,16870698
0,22.0,Fatigue,2,16870699
0,22.0,Thinking abnormal,3,16870701
0,22.0,Abdominal distension,3,16870702
1,22.0,Fatigue,3,16870702
0,22.1,Taste disorder,6,16870703
1,22.1,Asthenia,1,16870703
2,22.1,Abdominal distension,6,16870703
0,22.0,Swelling,3,16870704
1,22.0,Fatigue,3,16870704
2,22.0,Myalgia,3,16870704
0,22.1,Platelet count decreased,3,16870706
0,22.0,Insomnia,3,16870707
0,22.0,Rash,2,16870708
0,22.0,Nasopharyngitis,6,16870709
0,22.1,Nausea,3,16870710
1,22.1,Photosensitivity reaction,6,16870710
0,22.0,Adverse event,6,16870711
0,22.0,Headache,6,16870712
0,22.0,Drug ineffective,6,16870713
0,22.0,Decreased appetite,3,16870714
1,22.0,Dry mouth,3,16870714
2,22.0,Hypophagia,3,16870714
3,22.0,Dysgeusia,3,16870714
0,22.0,Fatigue,2,16870715
0,22.0,Asthenia,6,16870716
1,22.0,Fatigue,6,16870716
2,22.0,Pain,6,16870716
0,22.0,Rash,3,16870717
1,22.0,Photosensitivity reaction,3,16870717
0,22.0,Hypoaesthesia,3,16870718
0,22.0,Carbohydrate antigen 125 increased,6,16870720
0,22.0,Drug ineffective,6,16870721
1,22.0,Platelet count decreased,3,16870721
0,22.1,Urinary tract infection,3,16870723
0,22.1,Malignant neoplasm progression,6,16870724
1,22.1,Blood count abnormal,6,16870724
0,22.0,Scan abnormal,3,16870725
0,22.0,Hepatitis A,6,16870726
0,22.0,Malignant neoplasm progression,3,16870728
0,22.0,Hypoaesthesia,6,16870729
0,22.0,Myalgia,1,16870730
0,22.0,Insomnia,6,16870731
0,22.0,Taste disorder,3,16870732
0,22.0,Vomiting,1,16870733
1,22.0,Malaise,6,16870733
2,22.0,Nausea,1,16870733
0,22.0,Fatigue,6,16870734
0,22.1,Nausea,3,16870737
1,22.1,Adverse event,6,16870737
2,22.1,Decreased appetite,3,16870737
3,22.1,Abdominal pain,3,16870737
4,22.1,Vomiting,3,16870737
0,22.0,Nausea,3,16870738
1,22.0,Fatigue,3,16870738
0,22.0,Blood creatinine increased,6,16870739
0,22.0,Pain in extremity,6,16870740
1,22.0,Liver function test abnormal,1,16870740
2,22.0,Blood count abnormal,6,16870740
0,22.0,Hypersensitivity,1,16870741
1,22.0,Dizziness,6,16870741
2,22.0,Fatigue,6,16870741
3,22.0,Vertigo,1,16870741
4,22.0,Nausea,6,16870741
5,22.0,Constipation,1,16870741
6,22.0,Decreased appetite,6,16870741
7,22.0,Taste disorder,6,16870741
0,22.0,Fatigue,6,16870742
1,22.0,Dysgeusia,6,16870742
2,22.0,Decreased appetite,6,16870742
0,22.1,Skin discolouration,6,16870744
1,22.1,Taste disorder,6,16870744
2,22.1,Pruritus,6,16870744
3,22.1,Nausea,1,16870744
4,22.1,Product dose omission,6,16870744
5,22.1,Erythema,6,16870744
0,22.0,Drug intolerance,3,16870745
1,22.0,Vomiting,3,16870745
2,22.0,Feeding disorder,3,16870745
3,22.0,Dehydration,3,16870745
4,22.0,Nausea,3,16870745
0,22.0,Vomiting,6,16870746
1,22.0,Nausea,2,16870746
0,22.0,Vomiting,3,16870747
1,22.0,Fatigue,3,16870747
2,22.0,Nausea,3,16870747
0,22.0,Blister,6,16870748
0,22.0,Therapy non-responder,6,16870749
0,22.0,Nausea,6,16870750
0,22.0,Diarrhoea,6,16870751
0,22.0,Fatigue,6,16870752
1,22.0,Weight decreased,6,16870752
2,22.0,Decreased appetite,6,16870752
3,22.0,Product dose omission,6,16870752
4,22.0,Nausea,6,16870752
0,22.0,Haemoglobin decreased,6,16870754
1,22.0,White blood cell count decreased,6,16870754
0,22.0,Feeling abnormal,1,16870755
1,22.0,Nausea,1,16870755
2,22.0,Constipation,3,16870755
3,22.0,Fatigue,3,16870755
0,22.0,Product dose omission,6,16870756
0,22.0,Photosensitivity reaction,6,16870757
1,22.0,Skin exfoliation,6,16870757
0,22.0,Neoplasm,6,16870758
0,22.0,Abdominal distension,3,16870759
0,22.0,Fatigue,6,16870760
1,22.0,Somnolence,6,16870760
2,22.0,Affect lability,1,16870760
3,22.0,Nausea,6,16870760
0,22.0,Toxicity to various agents,6,16870762
0,22.1,Contusion,3,16870763
1,22.1,Decreased appetite,3,16870763
2,22.1,Haemoglobin decreased,6,16870763
3,22.1,Weight decreased,6,16870763
4,22.1,Red blood cell count decreased,3,16870763
5,22.1,White blood cell count decreased,3,16870763
6,22.1,Constipation,3,16870763
7,22.1,Viral infection,6,16870763
8,22.1,Fatigue,2,16870763
9,22.1,Dyspnoea,2,16870763
10,22.1,Dysgeusia,2,16870763
11,22.1,Product dose omission,6,16870763
12,22.1,Vomiting,6,16870763
13,22.1,Nausea,6,16870763
0,22.1,Blood count abnormal,3,16870764
1,22.1,Joint stiffness,6,16870764
2,22.1,Fatigue,6,16870764
0,22.0,Red blood cell count decreased,6,16870766
0,22.0,Renal function test abnormal,6,16870767
0,22.0,Nausea,1,16870768
0,22.0,Product dose omission,6,16870769
0,22.0,Anaemia,6,16870770
1,22.0,Fatigue,6,16870770
2,22.0,Product dose omission,6,16870770
0,22.1,Seasonal allergy,6,16870772
1,22.1,Chills,6,16870772
2,22.1,Malaise,6,16870772
0,22.0,Balance disorder,1,16870773
1,22.0,Nausea,1,16870773
0,22.1,Drug intolerance,6,16870774
1,22.1,Influenza like illness,6,16870774
2,22.1,Malaise,6,16870774
3,22.1,Malignant neoplasm progression,6,16870774
4,22.1,Headache,6,16870774
5,22.1,Platelet count decreased,6,16870774
6,22.1,Pain,6,16870774
7,22.1,Dyspnoea,6,16870774
8,22.1,Blood disorder,6,16870774
0,22.0,Ovarian cancer recurrent,6,16870775
0,22.0,Dyspnoea,6,16870776
1,22.0,Product dose omission,6,16870776
0,22.0,Accidental underdose,6,16870777
1,22.0,Renal disorder,6,16870777
0,22.0,Fatigue,1,16870778
0,22.1,Fatigue,3,16870779
1,22.1,Malignant neoplasm progression,6,16870779
2,22.1,Temperature intolerance,6,16870779
3,22.1,Photosensitivity reaction,6,16870779
4,22.1,Decreased appetite,3,16870779
5,22.1,Therapy partial responder,6,16870779
6,22.1,Insomnia,6,16870779
7,22.1,Carbohydrate antigen 125 increased,6,16870779
0,22.1,Renal disorder,3,16870780
1,22.1,Limb injury,6,16870780
2,22.1,Platelet disorder,3,16870780
3,22.1,Fatigue,6,16870780
4,22.1,Red blood cell count decreased,3,16870780
0,22.1,Fatigue,3,16870782
1,22.1,Product dose omission,6,16870782
2,22.1,Hair growth rate abnormal,6,16870782
3,22.1,Oropharyngeal pain,6,16870782
4,22.1,Peripheral swelling,6,16870782
5,22.1,Nausea,3,16870782
6,22.1,Dyspnoea exertional,6,16870782
7,22.1,Loss of personal independence in daily activities,6,16870782
8,22.1,Muscular weakness,6,16870782
9,22.1,Nasopharyngitis,6,16870782
10,22.1,Asthenia,3,16870782
11,22.1,Vomiting,6,16870782
0,22.1,Fatigue,3,16870783
1,22.1,Laboratory test abnormal,3,16870783
2,22.1,Dyspnoea,3,16870783
3,22.1,Nausea,3,16870783
4,22.1,Abdominal discomfort,3,16870783
5,22.1,Malignant neoplasm progression,6,16870783
0,22.0,Muscle spasms,2,16870784
1,22.0,Constipation,3,16870784
0,22.1,Anaemia,6,16870785
1,22.1,Fatigue,6,16870785
2,22.1,Malignant neoplasm progression,6,16870785
3,22.1,Contusion,6,16870785
4,22.1,Taste disorder,6,16870785
5,22.1,Decreased appetite,6,16870785
6,22.1,Constipation,6,16870785
0,22.0,Malaise,6,16870786
1,22.0,Malignant neoplasm progression,6,16870786
0,22.0,Nausea,6,16870787
1,22.0,Hypoaesthesia,2,16870787
0,22.0,Insomnia,3,16870788
1,22.0,Rash pruritic,1,16870788
2,22.0,Platelet count decreased,6,16870788
0,22.1,Weight decreased,3,16870789
1,22.1,Feeding disorder,3,16870789
2,22.1,Dehydration,6,16870789
3,22.1,Abdominal pain,6,16870789
4,22.1,Vomiting,6,16870789
5,22.1,Asthenia,3,16870789
6,22.1,Nausea,3,16870789
7,22.1,Decreased appetite,3,16870789
0,22.1,Foreign body in respiratory tract,3,16870791
1,22.1,Dizziness,3,16870791
2,22.1,White blood cell count decreased,6,16870791
3,22.1,Nausea,3,16870791
4,22.1,Nasopharyngitis,6,16870791
5,22.1,Product dose omission,6,16870791
6,22.1,Malaise,6,16870791
0,22.0,Rash,3,16870792
1,22.0,Nausea,6,16870792
2,22.0,Hepatic enzyme increased,6,16870792
0,22.0,Fatigue,6,16870793
1,22.0,Nausea,6,16870793
0,22.0,Constipation,3,16870794
1,22.0,Abdominal discomfort,3,16870794
2,22.0,Diarrhoea,3,16870794
0,22.1,Carbohydrate antigen 125 increased,3,16870796
1,22.1,Nausea,3,16870796
2,22.1,Transfusion,6,16870796
3,22.1,Fatigue,3,16870796
4,22.1,Malignant neoplasm progression,3,16870796
5,22.1,Haemangioma,3,16870796
0,22.0,Apathy,1,16870797
1,22.0,Fatigue,2,16870797
2,22.0,Nausea,1,16870797
0,22.1,Fatigue,3,16870798
1,22.1,Adverse event,6,16870798
2,22.1,Nausea,6,16870798
3,22.1,Taste disorder,6,16870798
0,22.1,Nausea,1,16870799
1,22.1,Product dose omission,6,16870799
2,22.1,Thirst,1,16870799
3,22.1,Stomatitis,1,16870799
4,22.1,Pollakiuria,1,16870799
0,22.0,Fatigue,3,16870800
0,22.1,Feeling hot,6,16870801
1,22.1,Unevaluable event,6,16870801
2,22.1,Fatigue,6,16870801
3,22.1,Pain,6,16870801
4,22.1,Abdominal pain,6,16870801
5,22.1,Drug ineffective,6,16870801
0,22.1,Liver function test abnormal,6,16870802
1,22.1,Fatigue,3,16870802
2,22.1,Dyspnoea,3,16870802
0,22.0,Feeding disorder,3,16870803
1,22.0,Insomnia,6,16870803
2,22.0,Dizziness,3,16870803
3,22.0,Malaise,3,16870803
4,22.0,Nausea,3,16870803
5,22.0,Lethargy,6,16870803
6,22.0,Fatigue,6,16870803
7,22.0,Bladder pain,3,16870803
8,22.0,Dysgeusia,2,16870803
9,22.0,Constipation,3,16870803
0,22.1,Blood count abnormal,6,16870804
1,22.1,Infection,6,16870804
0,22.0,Fatigue,3,16870805
0,22.0,Nausea,6,16870806
1,22.0,Fatigue,3,16870806
2,22.0,Flatulence,6,16870806
3,22.0,Taste disorder,6,16870806
4,22.0,Abdominal pain,6,16870806
5,22.0,Hot flush,6,16870806
6,22.0,Stomatitis,6,16870806
7,22.0,Hepatic enzyme increased,6,16870806
8,22.0,Pruritus,6,16870806
0,22.0,Abdominal discomfort,2,16870807
1,22.0,Fatigue,2,16870807
2,22.0,Nausea,2,16870807
